🔴 GH Research is trading 4.3% down today despite broader U.S. equities moving higher

GH Research is trading 4.3% down now at $28.93, despite broader U.S. equities moving higher on August 13, 2026, after softer-than-expected July PPI and easing Federal Reserve rate-hike expectations; the immediate catalyst is unclear.

• No company-specific announcement dated August 13, 2026, was identified.
• Recent developments, including August 6 quarterly results, Phase 3 preparation, and FDA feedback, were previously reported as positive, but no source directly connects them to the decline.
• The stock is underperforming the broader risk-on market.